|
70 Companies |
|
97 Products |
|
97 Products |
|
124 Mechanisms of Action |
|
1 Trial |
|
1962 News |
|
| «12...28293031323334353637383940» |
- | New P1/2 trial: Adolescent Involvement in Parental Substance Abuse Treatment (clinicaltrials.gov) - Apr 10, 2012
P1/2, N=183, Active, not recruiting, Sponsor: Ohio State University
- Trial completion: Screening Protocol for the Evaluation of Research Participants at the Maryland Psychiatric Research Center (MPRC) (clinicaltrials.gov) - Apr 10, 2012
P=N/A, N=5000, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting --> Completed
- bupropion sustained-release / Generic mfg.
New P4 trial: Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia (clinicaltrials.gov) - Apr 9, 2012
P4, N=17, Completed, Sponsor: Massachusetts General Hospital
- ||||| New P4 trial: Helping Hospitalized Patients Quit Smoking (clinicaltrials.gov) - Apr 9, 2012
P4, N=600, Recruiting, Sponsor: Mayo Clinic
- |||||||||| New P3 trial, Surgery: Decision Aid for Cigarette Smokers Undergoing Surgery (clinicaltrials.gov) - Apr 9, 2012
P3, N=170, Active, not recruiting, Sponsor: Mayo Clinic
- Enrollment change: Stress and Marijuana Cue-elicited Craving and Reactivity (clinicaltrials.gov) - Apr 8, 2012
P=N/A, N=87, Completed, Sponsor: Medical University of South Carolina
Recruiting --> Completed N=60 --> 87
- Enrollment change: ATIVR: Using Telephone Technology to Prevent Relapse After Alcoholism Treatment (clinicaltrials.gov) - Apr 8, 2012
P2, N=158, Completed, Sponsor: University of Vermont
N=60 --> 87 N=200 --> 158
- | Viibryd (vilazodone) / AbbVie
New P2 trial: Vilazodone Treatment for Marijuana Dependence (clinicaltrials.gov) - Apr 8, 2012
P2, N=76, Recruiting, Sponsor: Medical University of South Carolina
- Enrollment closed: Treatment for Adolescent Marijuana Abuse (clinicaltrials.gov) - Apr 8, 2012
P=N/A, N=153, Active, not recruiting, Sponsor: Dartmouth-Hitchcock Medical Center
N=200 --> 158 Recruiting --> Active, not recruiting
- Trial completion: Stress and Marijuana Cue-elicited Craving and Reactivity (clinicaltrials.gov) - Apr 8, 2012
P=N/A, N=87, Completed, Sponsor: Medical University of South Carolina
Recruiting --> Active, not recruiting Recruiting --> Completed
- Trial completion: ATIVR: Using Telephone Technology to Prevent Relapse After Alcoholism Treatment (clinicaltrials.gov) - Apr 8, 2012
P2, N=158, Completed, Sponsor: University of Vermont
Recruiting --> Completed Recruiting --> Completed
- || New P3 trial: "Effectiveness of a Brief Intervention for Substances Consumption Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): A Randomized Control Trial in Chilean Primary Care." (clinicaltrials.gov) - Apr 5, 2012
P3, N=400, Completed, Sponsor: Pontificia Universidad Catolica de Chile
- lorazepam / Generic mfg., dexmedetomidine / Generic mfg.
Clinical: Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD) (clinicaltrials.gov) - Apr 4, 2012
P4, N=150, Recruiting, Sponsor: Denver Health and Hospital Authority
Recruiting --> Completed Initiation date: Aug 2011 --> Mar 2012
- lorazepam / Generic mfg., dexmedetomidine / Generic mfg.
Clinical: Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD) (clinicaltrials.gov) - Apr 4, 2012
P4, N=150, Recruiting, Sponsor: Denver Health and Hospital Authority
Initiation date: Aug 2011 --> Mar 2012 Not yet recruiting --> Recruiting
- | New P1/2 trial: Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV (clinicaltrials.gov) - Apr 2, 2012
P1/2, N=138, Enrolling by invitation, Sponsor: Georgetown University
- topiramate / Generic mfg.
Enrollment closed: TAP: Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation Therapy (clinicaltrials.gov) - Apr 1, 2012
P4, N=30, Active, not recruiting, Sponsor: University of California, San Francisco
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Chantix (varenicline) / Pfizer
Trial completion: A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control (clinicaltrials.gov) - Mar 28, 2012
P=N/A, N=100, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting --> Active, not recruiting Recruiting --> Completed
- zonisamide / Generic mfg.
New P2 trial: Zonisamide for Heavy Drinkers With Bipolar Disorder (clinicaltrials.gov) - Mar 27, 2012
P2, N=40, Recruiting, Sponsor: VA Connecticut Healthcare System
- ||| buprenorphine/naloxone sublingual film / Generic mfg., buprenorphine sublingual tablets / Generic mfg.
Trial completion: Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444) (clinicaltrials.gov) - Mar 26, 2012
P=N/A, N=339, Completed, Sponsor: Reckitt Benckiser Pharmaceuticals Inc.
Recruiting --> Completed Recruiting --> Completed
- Enrollment change: p16 Methylation for Smoking Cessation (clinicaltrials.gov) - Mar 25, 2012
P=N/A, N=35, Completed, Sponsor: Duke University
Recruiting --> Completed N=50 --> 35
- dutasteride capsule / Generic mfg.
Biomarker, Enrollment change: Pharmacogenetics of Alcohol: Treatment Implications (clinicaltrials.gov) - Mar 25, 2012
P=N/A, N=94, Completed, Sponsor: University of Connecticut Health Center
N=50 --> 35 N=180 --> 94
- Trial completion: p16 Methylation for Smoking Cessation (clinicaltrials.gov) - Mar 25, 2012
P=N/A, N=35, Completed, Sponsor: Duke University
N=180 --> 94 Active, not recruiting --> Completed
- dutasteride capsule / Generic mfg.
Biomarker, Trial completion: Pharmacogenetics of Alcohol: Treatment Implications (clinicaltrials.gov) - Mar 25, 2012
P=N/A, N=94, Completed, Sponsor: University of Connecticut Health Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Vivitrol (naltrexone extended-release injectable suspension) / Alkermes
New P4 trial: Pre-Release VIVITROL for Opioid Dependent Inmates (clinicaltrials.gov) - Mar 22, 2012
P4, N=54, Recruiting, Sponsor: Rhode Island Hospital
- buprenorphine/naloxone sublingual film / Generic mfg., methadone / Generic mfg., buprenorphine sublingual tablets / Generic mfg.
New P1 trial: Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution (clinicaltrials.gov) - Mar 20, 2012
P1, N=40, Recruiting, Sponsor: Johns Hopkins University
- methylphenidate tablet / Generic mfg.
Enrollment open: Psychopharmacology for Cocaine Dependence - Buspirone (clinicaltrials.gov) - Mar 20, 2012
P1/2, N=36, Recruiting, Sponsor: The University of Texas Health Science Center, Houston
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Trial termination: Integrated Intervention for Substance Abusers With Depressive Disorders (clinicaltrials.gov) - Mar 19, 2012
P2, N=276, Terminated, Sponsor: Department of Veterans Affairs
Not yet recruiting --> Recruiting Active, not recruiting --> Terminated
- Trial withdrawal: Pilot Study Repetitive Transcranial Magnetic Stimulation (rTMS) in Cannabis Craving (clinicaltrials.gov) - Mar 15, 2012
P1, N=0, Withdrawn, Sponsor: National Institute on Drug Abuse (NIDA)
Active, not recruiting --> Terminated Not yet recruiting --> Withdrawn
- Enrollment change: Pilot Study Repetitive Transcranial Magnetic Stimulation (rTMS) in Cannabis Craving (clinicaltrials.gov) - Mar 15, 2012
P1, N=0, Withdrawn, Sponsor: National Institute on Drug Abuse (NIDA)
Not yet recruiting --> Withdrawn N=45 --> 0
- Enrollment closed: Computer-Based Alcohol Use Disorder Recovery System (clinicaltrials.gov) - Mar 15, 2012
P=N/A, N=350, Active, not recruiting, Sponsor: University of Wisconsin, Madison
N=45 --> 0 Recruiting --> Active, not recruiting
- Enrollment change: Natural History of Attempts to Stop Smoking (clinicaltrials.gov) - Mar 14, 2012
P=N/A, N=238, Completed, Sponsor: University of Vermont
Recruiting --> Active, not recruiting N=300 --> 238
- Trial completion: Natural History of Attempts to Stop Smoking (clinicaltrials.gov) - Mar 14, 2012
P=N/A, N=238, Completed, Sponsor: University of Vermont
N=300 --> 238 Active, not recruiting --> Completed
- Enrollment change: Effects of Sulfasalazine on BOLD Response to Alcohol Cues (clinicaltrials.gov) - Mar 12, 2012
P=N/A, N=23, Completed, Sponsor: The Mind Research Network
Active, not recruiting --> Completed N=30 --> 23
- atomoxetine / Generic mfg.
Enrollment change: Atomoxetine Treatment for ADHD and Marijuana Dependence (clinicaltrials.gov) - Mar 12, 2012
P2, N=38, Completed, Sponsor: Medical University of South Carolina
N=30 --> 23 N=70 --> 38
- Biomarker, Trial completion: Promoting Home Smoking Restrictions: Biomarker Feedback to Smoking and Non-Smoking Adults (clinicaltrials.gov) - Mar 12, 2012
P=N/A, N=122, Completed, Sponsor: Masonic Cancer Center, University of Minnesota
N=70 --> 38 Active, not recruiting --> Completed
- Trial completion: Effects of Sulfasalazine on BOLD Response to Alcohol Cues (clinicaltrials.gov) - Mar 12, 2012
P=N/A, N=23, Completed, Sponsor: The Mind Research Network
Active, not recruiting --> Completed Recruiting --> Completed
- | olanzapine / Generic mfg.
Enrollment change: A New Pharmacotherapy for Alcohol Dependence: Olanzapine (clinicaltrials.gov) - Mar 11, 2012
P3, N=304, Completed, Sponsor: The Mind Research Network
Recruiting --> Completed N=192 --> 304
- modafinil / Generic mfg.
Enrollment change: Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents (clinicaltrials.gov) - Mar 11, 2012
P1, N=24, Completed, Sponsor: University of Kentucky
N=192 --> 304 N=100 --> 24
- tramadol hcl extended-release / Generic mfg., tramadol hydrochloride / Generic mfg.
Trial completion: Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal (clinicaltrials.gov) - Mar 11, 2012
P2/3, N=45, Completed, Sponsor: University of Kentucky
N=100 --> 24 Recruiting --> Completed
- modafinil / Generic mfg.
Trial completion: Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents (clinicaltrials.gov) - Mar 11, 2012
P1, N=24, Completed, Sponsor: University of Kentucky
Recruiting --> Completed Recruiting --> Completed
- Enrollment open: Way to Quit - Comparative Efficacy, Acceptance and Effectiveness of Health Incentive Structures (clinicaltrials.gov) - Mar 7, 2012
P=N/A, N=2185, Enrolling by invitation, Sponsor: University of Pennsylvania
Recruiting --> Completed Not yet recruiting --> Enrolling by invitation
- Trial completion: Youth Drug Abuse Family and Cognitive-Behavioral Therapy (clinicaltrials.gov) - Mar 7, 2012
P2, N=296, Completed, Sponsor: University of Florida
Not yet recruiting --> Enrolling by invitation Active, not recruiting --> Completed
- Trial termination, IO biomarker: Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia (clinicaltrials.gov) - Mar 6, 2012
P2, N=23, Terminated, Sponsor: British Columbia Cancer Agency
Active, not recruiting --> Completed Recruiting --> Terminated; Slow recruitment
- Enrollment change, IO biomarker: Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia (clinicaltrials.gov) - Mar 6, 2012
P2, N=23, Terminated, Sponsor: British Columbia Cancer Agency
Recruiting --> Terminated; Slow recruitment N=110 --> 23
- Enrollment change: Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum (clinicaltrials.gov) - Mar 6, 2012
P2, N=53, Completed, Sponsor: British Columbia Cancer Agency
N=110 --> 23 N=120 --> 53
- Korlym (mifepristone) / Corcept Therap
New P2 trial: Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists (clinicaltrials.gov) - Mar 6, 2012
P2, N=50, Recruiting, Sponsor: The Scripps Research Institute
- Trial completion: Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum (clinicaltrials.gov) - Mar 6, 2012
P2, N=53, Completed, Sponsor: British Columbia Cancer Agency
N=120 --> 53 Active, not recruiting --> Completed
- Enrollment change: Acceptability of Less Harmful Alternatives to Cigarettes (clinicaltrials.gov) - Mar 4, 2012
P=N/A, N=67, Completed, Sponsor: Roswell Park Cancer Institute
Active, not recruiting --> Completed N=100 --> 67
- Enrollment open: Emerging Adults Who Use Alcohol and Marijuana (clinicaltrials.gov) - Mar 4, 2012
P4, N=500, Recruiting, Sponsor: Butler Hospital
N=100 --> 67 Not yet recruiting --> Recruiting
- Trial completion: Acceptability of Less Harmful Alternatives to Cigarettes (clinicaltrials.gov) - Mar 4, 2012
P=N/A, N=67, Completed, Sponsor: Roswell Park Cancer Institute
Not yet recruiting --> Recruiting Active, not recruiting --> Completed